Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: Results for CALGB 10404 (Alliance)

John C. Byrd; Amy S. Ruppert; Nyla A. Heerema; Alese E. Halvorson; Eva Hoke; Mitchell R. Smith; John E. Godwin; Stephen Couban; Todd A. Fehniger; Michael J. Thirman; Martin S. Tallman; Frederick R. Appelbaum; Richard M. Stone; Sue Robinson; Julie E. Chang; Sumithra J. Mandrekar; Richard A. Larson

doi:10.1182/bloodadvances.2017015396

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: Results for CALGB 10404 (Alliance)

John C. Byrd, Amy S. Ruppert, Nyla A. Heerema, Alese E. Halvorson, Eva Hoke, Mitchell R. Smith, John E. Godwin, Stephen Couban, Todd A. Fehniger, Michael J. Thirman, Martin S. Tallman, Frederick R. Appelbaum, Richard M. Stone, Sue Robinson, Julie E. Chang, Sumithra J. Mandrekar, Richard A. Larson

Research output: Contribution to journal › Article › peer-review

18 Citations (Scopus)

Original language	English
Pages (from-to)	1705-1718
Number of pages	14
Journal	Blood Advances
Volume	2
Issue number	14
DOIs	https://doi.org/10.1182/bloodadvances.2017015396
Publication status	Published - Jul 24 2018
Externally published	Yes

ASJC Scopus Subject Areas

Hematology

Access to Document

10.1182/bloodadvances.2017015396

Cite this

Byrd, J. C., Ruppert, A. S., Heerema, N. A., Halvorson, A. E., Hoke, E., Smith, M. R., Godwin, J. E., Couban, S., Fehniger, T. A., Thirman, M. J., Tallman, M. S., Appelbaum, F. R., Stone, R. M., Robinson, S., Chang, J. E., Mandrekar, S. J., & Larson, R. A. (2018). Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: Results for CALGB 10404 (Alliance). Blood Advances, 2(14), 1705-1718. https://doi.org/10.1182/bloodadvances.2017015396

Byrd, JC, Ruppert, AS, Heerema, NA, Halvorson, AE, Hoke, E, Smith, MR, Godwin, JE, Couban, S, Fehniger, TA, Thirman, MJ, Tallman, MS, Appelbaum, FR, Stone, RM, Robinson, S, Chang, JE, Mandrekar, SJ & Larson, RA 2018, 'Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: Results for CALGB 10404 (Alliance)', Blood Advances, vol. 2, no. 14, pp. 1705-1718. https://doi.org/10.1182/bloodadvances.2017015396

@article{e8091bfd3d58431db0cc0ba2c14bb563,

title = "Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: Results for CALGB 10404 (Alliance)",

author = "Byrd, {John C.} and Ruppert, {Amy S.} and Heerema, {Nyla A.} and Halvorson, {Alese E.} and Eva Hoke and Smith, {Mitchell R.} and Godwin, {John E.} and Stephen Couban and Fehniger, {Todd A.} and Thirman, {Michael J.} and Tallman, {Martin S.} and Appelbaum, {Frederick R.} and Stone, {Richard M.} and Sue Robinson and Chang, {Julie E.} and Mandrekar, {Sumithra J.} and Larson, {Richard A.}",

note = "Publisher Copyright: {\textcopyright} 2018 by The American Society of Hematology.",

year = "2018",

month = jul,

day = "24",

doi = "10.1182/bloodadvances.2017015396",

language = "English",

volume = "2",

pages = "1705--1718",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "Elsevier BV",

number = "14",

}

TY - JOUR

T1 - Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy

T2 - Results for CALGB 10404 (Alliance)

AU - Byrd, John C.

AU - Ruppert, Amy S.

AU - Heerema, Nyla A.

AU - Halvorson, Alese E.

AU - Hoke, Eva

AU - Smith, Mitchell R.

AU - Godwin, John E.

AU - Couban, Stephen

AU - Fehniger, Todd A.

AU - Thirman, Michael J.

AU - Tallman, Martin S.

AU - Appelbaum, Frederick R.

AU - Stone, Richard M.

AU - Robinson, Sue

AU - Chang, Julie E.

AU - Mandrekar, Sumithra J.

AU - Larson, Richard A.

PY - 2018/7/24

Y1 - 2018/7/24

UR - http://www.scopus.com/inward/record.url?scp=85059827893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059827893&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2017015396

DO - 10.1182/bloodadvances.2017015396

M3 - Article

C2 - 30030269

AN - SCOPUS:85059827893

SN - 2473-9529

VL - 2

SP - 1705

EP - 1718

JO - Blood Advances

JF - Blood Advances

IS - 14

ER -

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: Results for CALGB 10404 (Alliance)

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this